Navigation Links
Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results
Date:8/13/2009

REDWOOD CITY, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today reported financial results and corporate progress for its fiscal 2009 fourth quarter and year ended June 30, 2009.

"With a slower than expected rate of clinical adoption for our automated anastomosis products, during our fiscal fourth quarter we had to make difficult decisions to revise our direct sales model cost structure by reducing our workforce and decreasing operating expenses substantially to protect the future viability of our products and technology," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica.

"We continue to evaluate a variety of strategic and financing alternatives and believe that our products and proprietary technology have the potential to generate substantial value in the future," continued Dr. Hausen. "To that end, we are in the process of adding independent distributors and manufacturer's representatives to support our core direct sales team in order to contain sales costs while still serving our customers and potential customers for our automated anastomosis product line. Looking beyond cardiac surgery, we are shifting our development efforts to focus on our endoscopic microcutter, which would expand our commercial opportunity into additional surgical markets."

Recent Highlights and Accomplishments

  • Increased cumulative worldwide shipments of PAS-Port(R) Proximal Anastomosis Systems to over 15,000 units, with a total of 1,051 units sold in the fourth quarter of fiscal 2009;
  • Increased cumulative worldwide shipments of C-Port(R) Distal Anastomosis Systems to over 9,300 units, with a total of 555 units sold in the fourth quarter of fiscal 2009;

  • '/>"/>

SOURCE Cardica, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Cardica Announces Proposed Public Offering of Common Stock
2. Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock
3. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
4. Cardica Announces Exercise of Over-Allotment Option
5. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
6. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
7. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
8. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
9. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
10. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
11. Cardica Names Frederick Bauer Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Austin, Texas (PRWEB) September 22, 2014 ... testing and treatment, will work with companies to help ... prevent the development of diabetes as part of a ... Stop Diabetes @ Work initiative. , PreDiabetes Centers ... Texas Department of Transportation in Austin on Tuesday, October ...
(Date:9/22/2014)... Steven Reinberg HealthDay Reporter ... that bacterial pneumonia can raise your risk of heart problems, ... and kill heart cells, increasing the chances of heart failure, ... report. In mice, monkeys and human heart tissue, researchers ... and they tried a vaccine that might one day prevent ...
(Date:9/22/2014)... At the 10th Clinton Global ... Partnership (SNP) announced the successful launch of a ... Risk Reduction Program for Women. The announcement of ... their risk of heart disease through a seafood-rich ... for addressing significant global challenges made by CGI ...
(Date:9/22/2014)... Burbank, CA (PRWEB) September 22, 2014 ... social and mobile recruiting, announced today an ... talent management solutions for the healthcare industry. ... to TweetMyJobs’ suite of social recruiting solutions ... management software designed specifically for healthcare organizations. ...
(Date:9/22/2014)... -- In a collaboration that will encompass a ... and patient care and accelerate personalized genomic medicine, ... Medical Center (BIDMC) have established a new academic, ... today. , A recently signed agreement calls for ... a comprehensive relationship in the areas of research ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 3Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 2Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 2Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 3Health News:At 2014 Clinton Global Initiative Annual Meeting, Seafood Nutrition Partnership Announces Pilot Program to Reduce Women’s Heart Disease Risks 4Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 2Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 3Health News:TweetMyJobs and HealthcareSource Partner To Provide Social Recruiting Solutions to Healthcare Organizations 4Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 2Health News:The Jackson Laboratory and BIDMC announce multifaceted affiliation 3
... Mary Bono Mack (CA-45) and Nita Lowey (NY-18) ... and well-being of American youth by reintroducing the ... The bipartisan legislation, broadly supported by such organizations ... cross-sector collaboration for improving the health of young ...
... (Nasdaq: MDTH ), (the "Company") a healthcare ... and treatment of cardiovascular disease, today announced that it has ... quarter ended March 31, 2009 and the filing of its ... as a result of an ongoing internal assessment by the ...
... nation,s leading cardioelectrophysiologists, has joined The Mount Sinai Medical Center as ... ... (Vocus)-- Vivek Y. Reddy, M.D., one of the nation,s leading cardioelectrophysiologists, ... of Electrophysiology Laboratories. His appointment becomes effective July 1., , ...
... C. Kolars, M.D., has been named the University ... for Education and Global Initiatives, effective June 1, pending the ... the Medical School,s lead for the oversight and expansion of ... James O. Woolliscroft , M.D., the medical school,s ...
... Fund now has within its reach the potential to ... meeting in Geneva, the Board of Directors of the ... Fund), today agreed to enhance the Fund,s response to ... prevent mother-to-child transmission of HIV (PMTCT), thereby opening the ...
... of the Clopidogrel Medco Outcomes Study presented today during SCAI,s ... may be reduced when taken concurrently with commonly used heartburn ... patients taking clopidogrel and a PPI experienced a: , ... 50% increase in the combined risk of hospitalization for heart ...
Cached Medicine News:Health News:Bono Mack, Lowey Introduce Bill To Improve the Health of Youth 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 2Health News:Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories 3Health News:Joseph C. Kolars, M.D., to be U-M Medical School's First Senior Associate Dean for Education and Global Initiatives 2Health News:GAA Applauds Global Fund's Decision to Accelerate Support for Treatment Strategies to Prevent Mother-to-Child Transmission of HIV 2Health News:SCAI Statement on 'A National Study of the Effect of Individual Proton Pump Inhibitors on Cardiovascular Outcomes in Patients Treated with Clopidogrel Following Coronary Stenting: The Clopidogrel Medco Outcomes Study' 2
(Date:9/22/2014)... 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) ... 2014 ended July 31, 2014 on Monday, September 29 before ... the results at 11:00 AM ET. Participating in the call ... A. Krakauer , President and CEO; Jorgen B. Hansen ... , Senior Vice President, CFO and Treasurer; and Seth ...
(Date:9/22/2014)...  For many people experiencing issues with their ... prospect of large, painful incisions and long recovery ... also impacted, such as working, driving and even ... some patients even delay necessary treatment, resorting to ... permanent damage for some conditions. Logo ...
(Date:9/22/2014)... PLYMOUTH MEETING, Pa. , Sept. 22, 2014 ... ) announced today it has initiated a phase ... The trial will evaluate the safety, tolerability, and ... type 6 (HPV-6), which causes most aerodigestive cancers. ... tongue, nose, throat, vocal cords, and parts of ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4
... SPRING, Md., March 11 In a boost to,HIV ... provide a,royalty-free license to the non-profit International Partnership for,Microbicides ... as a,potential vaginal microbicide., The compound, called L,644, ... as gp41 fusion inhibitors, which inhibit HIV infection by,preventing ...
... data provides evidence for, potential benefit of starting Femara up to seven years after ... tamoxifen, ... published in Journal of Clinical Oncology, - Half of all breast cancer recurrences occur ... ...
Cached Medicine Technology:Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 2Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 2VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 4VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 5VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 6VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 7
... to 17 parameters from just 95 ... blood gases, as well as any ... metabolite parameters. Unique technology reduces to ... substances have on the accuracy of ...
... a sophisticated whole blood analysis system that ... also satisfying the stringent requirements of the ... contains all of the components of a ... the sampling unit, all of the sensors ...
... The Rapidlab 800 System is a ... key critical care whole blood parameters in ... modular design allows the basic blood gas ... to include electrolytes, metabolites and CO-oximetry in ...
This compact, easy-to-operate analyzer delivers basic blood gas, ISEs with direct measured total hemoglobin and saturated oxygen. Use it as a cost effective backup for the central lab or for remote p...
Medicine Products: